Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Skyrocketed 126% in November


Shares of clinical-stage biotech Moderna (NASDAQ: MRNA) soared 126% in November, according to data from S&P Global Market Intelligence. For context, the S&P 500 returned 11% last month.

In 2020, Moderna stock has rocketed 680% through Friday, Dec. 4, compared to the broader market's 16.5% return over this period.  

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments